Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? Review

Siker, Malika L, Chakravarti, Arnab, Mehta, Minesh P. (2006). Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma? . Critical Reviews in Oncology/Hematology, 60(2), 99-111. 10.1016/j.critrevonc.2006.04.005

keywords

  • CARMUSTINE PLUS O-6-BENZYLGUANINE
  • DIAGNOSED GLIOBLASTOMA-MULTIFORME
  • GROWTH-FACTOR RECEPTOR
  • Hematology
  • Life Sciences & Biomedicine
  • MISMATCH REPAIR-DEFICIENT
  • MOTEXAFIN GADOLINIUM
  • O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE
  • O-6-METHYLGUANINE DNA METHYLTRANSFERASE
  • Oncology
  • PHASE-II TRIAL
  • POLY(ADP-RIBOSE) POLYMERASE-1 INHIBITOR
  • Science & Technology
  • VINCRISTINE PCV CHEMOTHERAPY
  • anaplastic glioma
  • astrocytoma
  • chemoradiotherapy
  • chemotherapy
  • oligoastrocytoma
  • oligodendroglioma
  • radiotherapy
  • temozolomide

Digital Object Identifier (DOI)

start page

  • 99

end page

  • 111

volume

  • 60

issue

  • 2